Abstract

We analyzed molecular data on 2,579 tumors from The Cancer Genome Atlas (TCGA) of four gynecological types plus breast. Our aims were to identify shared and unique molecular features, clinically significant subtypes, and potential therapeutic targets. We found 61 somatic copy-number alterations (SCNAs) and 46 significantly mutated genes (SMGs). Eleven SCNAs and 11 SMGs had not been identified in previous TCGA studies of the individual tumor types. We found functionally significant estrogen receptor-regulated long non-coding RNAs (lncRNAs) and gene/lncRNA interaction networks. Pathway analysis identified subtypes with high leukocyte infiltration, raising potential implications for immunotherapy. Using 16 key molecular features, we identified five prognostic subtypes and developed a decision tree that classified patients into the subtypes based on just six features that are assessable in clinical laboratories. By performing molecular analyses of 2,579 TCGA gynecological (OV, UCEC, CESC, and UCS) and breast tumors, Berger et al. identify five prognostic subtypes using 16 key molecular features and propose a decision tree based on six clinically assessable features that classifies patients into the subtypes.

LanguageEnglish (US)
Pages690-705.e9
JournalCancer Cell
Volume33
Issue number4
DOIs
StatePublished - Apr 9 2018

Fingerprint

Breast Neoplasms
Atlases
Long Noncoding RNA
Decision Trees
Genome
Neoplasms
Genes
Estrogen Receptors
Immunotherapy
Breast
Leukocytes
Therapeutics

Keywords

  • TCGA
  • The Cancer Genome Atlas
  • breast cancer
  • cervical cancer
  • gynecologic cancer
  • omics
  • ovarian cancer
  • pan-gynecologic
  • uterine cancer
  • uterine carcinosarcoma

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Cite this

A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. / The Cancer Genome Atlas Research Network.

In: Cancer Cell, Vol. 33, No. 4, 09.04.2018, p. 690-705.e9.

Research output: Contribution to journalArticle

The Cancer Genome Atlas Research Network. / A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. In: Cancer Cell. 2018 ; Vol. 33, No. 4. pp. 690-705.e9.
@article{b107b01d60a94044a61ee7bfb6bc51ab,
title = "A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers",
abstract = "We analyzed molecular data on 2,579 tumors from The Cancer Genome Atlas (TCGA) of four gynecological types plus breast. Our aims were to identify shared and unique molecular features, clinically significant subtypes, and potential therapeutic targets. We found 61 somatic copy-number alterations (SCNAs) and 46 significantly mutated genes (SMGs). Eleven SCNAs and 11 SMGs had not been identified in previous TCGA studies of the individual tumor types. We found functionally significant estrogen receptor-regulated long non-coding RNAs (lncRNAs) and gene/lncRNA interaction networks. Pathway analysis identified subtypes with high leukocyte infiltration, raising potential implications for immunotherapy. Using 16 key molecular features, we identified five prognostic subtypes and developed a decision tree that classified patients into the subtypes based on just six features that are assessable in clinical laboratories. By performing molecular analyses of 2,579 TCGA gynecological (OV, UCEC, CESC, and UCS) and breast tumors, Berger et al. identify five prognostic subtypes using 16 key molecular features and propose a decision tree based on six clinically assessable features that classifies patients into the subtypes.",
keywords = "TCGA, The Cancer Genome Atlas, breast cancer, cervical cancer, gynecologic cancer, omics, ovarian cancer, pan-gynecologic, uterine cancer, uterine carcinosarcoma",
author = "{The Cancer Genome Atlas Research Network} and Berger, {Ashton C.} and Anil Korkut and Anil Korkut and Kanchi, {Rupa Sridevi} and Walter Lenoir and Wenbin Liu and Yuexin Liu and Yuexin Liu and Hui Shen and Visweswaran Ravikumar and Arvind Rao and {Uppore Kukkillaya}, {Arvind Rao} and {Uppore Kukkillaya}, {Arvind Rao} and Pavel Sumazin and Cecilia Williams and Pieter Mestdagh and Gunaratne, {Preethi H.} and Christina Yau and Reanne Bowlby and Sood, {Anil K} and Alexander Lazar and Baggerly, {Keith A} and Janos Roszik and Rehan Akbani and Broom, {Bradley McIntosh} and Shiyun Ling and Yiling Lu and Mills, {Gordon B} and Weinstein, {John N} and Xiuping Liu and Linghua Wang and Carvalho, {Andr{\'e} L.} and Fregnani, {Jos{\'e} Humberto T. G.} and Scapulatempo, {Cristovam Neto} and Ajani, {Jaffer A} and Behrens, {Maria del Carmen} and Russell Broaddus and Czerniak, {Bogdan A} and Bita Esmaeli and Junya Fujimoto and Gershenwald, {Jeffrey E} and Logothetis, {Christopher J} and Funda Meric-Bernstam and Cesar Moran and Ramondetta, {Lois M} and Pheroze Tamboli and Timothy Thompson and Patricia Troncoso and Anne Tsao and {von Deimling}, Andreas",
year = "2018",
month = "4",
day = "9",
doi = "10.1016/j.ccell.2018.03.014",
language = "English (US)",
volume = "33",
pages = "690--705.e9",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers

AU - The Cancer Genome Atlas Research Network

AU - Berger, Ashton C.

AU - Korkut, Anil

AU - Korkut, Anil

AU - Kanchi, Rupa Sridevi

AU - Lenoir, Walter

AU - Liu, Wenbin

AU - Liu, Yuexin

AU - Liu, Yuexin

AU - Shen, Hui

AU - Ravikumar, Visweswaran

AU - Rao, Arvind

AU - Uppore Kukkillaya, Arvind Rao

AU - Uppore Kukkillaya, Arvind Rao

AU - Sumazin, Pavel

AU - Williams, Cecilia

AU - Mestdagh, Pieter

AU - Gunaratne, Preethi H.

AU - Yau, Christina

AU - Bowlby, Reanne

AU - Sood, Anil K

AU - Lazar, Alexander

AU - Baggerly, Keith A

AU - Roszik, Janos

AU - Akbani, Rehan

AU - Broom, Bradley McIntosh

AU - Ling, Shiyun

AU - Lu, Yiling

AU - Mills, Gordon B

AU - Weinstein, John N

AU - Liu, Xiuping

AU - Wang, Linghua

AU - Carvalho, André L.

AU - Fregnani, José Humberto T. G.

AU - Scapulatempo, Cristovam Neto

AU - Ajani, Jaffer A

AU - Behrens, Maria del Carmen

AU - Broaddus, Russell

AU - Czerniak, Bogdan A

AU - Esmaeli, Bita

AU - Fujimoto, Junya

AU - Gershenwald, Jeffrey E

AU - Logothetis, Christopher J

AU - Meric-Bernstam, Funda

AU - Moran, Cesar

AU - Ramondetta, Lois M

AU - Tamboli, Pheroze

AU - Thompson, Timothy

AU - Troncoso, Patricia

AU - Tsao, Anne

AU - von Deimling, Andreas

PY - 2018/4/9

Y1 - 2018/4/9

N2 - We analyzed molecular data on 2,579 tumors from The Cancer Genome Atlas (TCGA) of four gynecological types plus breast. Our aims were to identify shared and unique molecular features, clinically significant subtypes, and potential therapeutic targets. We found 61 somatic copy-number alterations (SCNAs) and 46 significantly mutated genes (SMGs). Eleven SCNAs and 11 SMGs had not been identified in previous TCGA studies of the individual tumor types. We found functionally significant estrogen receptor-regulated long non-coding RNAs (lncRNAs) and gene/lncRNA interaction networks. Pathway analysis identified subtypes with high leukocyte infiltration, raising potential implications for immunotherapy. Using 16 key molecular features, we identified five prognostic subtypes and developed a decision tree that classified patients into the subtypes based on just six features that are assessable in clinical laboratories. By performing molecular analyses of 2,579 TCGA gynecological (OV, UCEC, CESC, and UCS) and breast tumors, Berger et al. identify five prognostic subtypes using 16 key molecular features and propose a decision tree based on six clinically assessable features that classifies patients into the subtypes.

AB - We analyzed molecular data on 2,579 tumors from The Cancer Genome Atlas (TCGA) of four gynecological types plus breast. Our aims were to identify shared and unique molecular features, clinically significant subtypes, and potential therapeutic targets. We found 61 somatic copy-number alterations (SCNAs) and 46 significantly mutated genes (SMGs). Eleven SCNAs and 11 SMGs had not been identified in previous TCGA studies of the individual tumor types. We found functionally significant estrogen receptor-regulated long non-coding RNAs (lncRNAs) and gene/lncRNA interaction networks. Pathway analysis identified subtypes with high leukocyte infiltration, raising potential implications for immunotherapy. Using 16 key molecular features, we identified five prognostic subtypes and developed a decision tree that classified patients into the subtypes based on just six features that are assessable in clinical laboratories. By performing molecular analyses of 2,579 TCGA gynecological (OV, UCEC, CESC, and UCS) and breast tumors, Berger et al. identify five prognostic subtypes using 16 key molecular features and propose a decision tree based on six clinically assessable features that classifies patients into the subtypes.

KW - TCGA

KW - The Cancer Genome Atlas

KW - breast cancer

KW - cervical cancer

KW - gynecologic cancer

KW - omics

KW - ovarian cancer

KW - pan-gynecologic

KW - uterine cancer

KW - uterine carcinosarcoma

UR - http://www.scopus.com/inward/record.url?scp=85044909989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044909989&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2018.03.014

DO - 10.1016/j.ccell.2018.03.014

M3 - Article

VL - 33

SP - 690-705.e9

JO - Cancer Cell

T2 - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 4

ER -